Gut-central nervous system axis is a target for nutritional therapies

Nutrition Journal

Volumn 11, Issue 1, 2012, Pages

  Pimentel, Gustavo D ^a,e   Micheletti, Thayana O ^a   Pace, Fernanda ^a   Rosa, José C ^b   Santos, Ronaldo V T ^c   Lira, Fabio S ^d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^e José Caetano de Lima ^*  (Brazil)

Author keywords

Appetite; Central nervous system; Diet; Gut; Inflammatory disease; Nutrition

Indexed keywords

GAMMA INTERFERON; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; SEROTONIN; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; GASTROINTESTINAL HORMONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOREXIA; APPETITE; BACTEROIDETES; BARIATRIC SURGERY; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CROHN DISEASE; DIET; DISEASE ASSOCIATION; ENERGY EXPENDITURE; FIRMICUTES; FOOD INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTHALAMUS; INTESTINE; LACTOBACILLUS; MICROFLORA; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITION; OBESITY; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW; ULCERATIVE COLITIS; DIET THERAPY; ENTERITIS; GASTROINTESTINAL TRACT; METABOLISM; METAGENOME; MICROBIOLOGY; POSTPRANDIAL STATE;

APPETITE REGULATION; BARIATRIC SURGERY; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 2; DIET; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; METAGENOME; OBESITY; POSTPRANDIAL PERIOD;

EID: 84859510694     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-11-22     Document Type: Review

References (100)

1. Oxintomodulina e obesidade. Pimentel GD MJ, Mota JF, Oyama LM, Rev Nutr 2009 22 727 737 10.1590/S1415-52732009000500013
2. [Foods and nutrients modulates the release of anorexigenic gastrointestinal hormones]. Pimentel GD, Zemdegs JC, Acta Med Port 2010 23 891 900 21144331
3. Gut feelings: the emerging biology of gut-brain communication. Mayer EA, Nat Rev Neurosci 2011 12 453 466 21750565
4. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Washington MC, Raboin SJ, Thompson W, Larsen CJ, Sayegh AI, Brain Res 2010 1344 124 133 20452329
5. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M, FASEB J 2004 18 439 456 10.1096/fj.03-0641rev 15003990 (Pubitemid 38326301)
6. Circulating leptin and cortisol after burn injury: loss of diurnal pattern. Hobson KG, Havel PJ, McMurtry AL, Lawless MB, Palmieri TL, Greenhalgh DD, J Burn Care Rehabil 2004 25 491 499 10.1097/01.BCR.0000144532.02792.6E 15534457 (Pubitemid 39491903)
7. Improving food intake in anorectic cancer patients. Laviano A, Meguid MM, Rossi-Fanelli F, Curr Opin Clin Nutr Metab Care 2003 6 421 426 12806216 (Pubitemid 40684594)
8. Hypothalamic inflammation and energy homeostasis: resolving the paradox. Thaler JP, Choi SJ, Schwartz MW, Wisse BE, Front Neuroendocrinol 2010 31 79 84 10.1016/j.yfrne.2009.10.002 19822168
9. Intake of trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFkappaBp65 signaling in adult offspring. Pimentel GD, Lira FS, Rosa JC, Oliveira JL, Losinskas-Hachul AC, Souza GI, das Gracas TdCM, Santos RV, de Mello MT, Tufik S, et al. J Nutr Biochem 2012 23 265 271 10.1016/j.jnutbio.2010.12.003 21543208
10. The Relation between Longevity and Obesity in Human Beings. Pauling L, Proc Natl Acad Sci USA 1958 44 619 622 10.1073/pnas.44.6.619 16590251
11. Hypothalamic lesions and adiposity in the rat. Hetherington AW RS, Anat Rec 1940 78 149 172 10.1002/ar.1090780203
12. Hypothalamic control of food intake in rats and cats. Anand BK, Brobeck JR, Yale J Biol Med 1951 24 123 140 14901884
13. Recovery from the failure to eat produced by hypothalamic lesions. Teitelbaum P, Stellar E, Science 1954 120 894 895 10.1126/science.120.3126.894 13216188
14. Experiments on motivation. Studies combining psychological, physiological, and pharmacological techniques. Miller NE, Science 1957 126 1271 1278 10.1126/science.126.3286.1271 13495454
15. Positional cloning of the mouse obese gene and its human homologue. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM, Nature 1994 372 425 432 10.1038/372425a0 7984236 (Pubitemid 24365442)
16. Hypothalamic control of energy balance: different peptides, different functions. Leibowitz SF, Wortley KE, Peptides 2004 25 473 504 10.1016/j.peptides.2004.02.006 15134868 (Pubitemid 38591557)
17. Central nervous system control of food intake. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG, Nature 2000 404 661 671 10766253 (Pubitemid 30205071)
18. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. Valentino MA, Lin JE, Snook AE, Li P, Kim GW, Marszalowicz G, Magee MS, Hyslop T, Schulz S, Waldman SA, J Clin Invest 2011 121 3578 3588 10.1172/JCI57925 21865642
19. The microbiome-gut-brain axis: from bowel to behavior. Cryan JF, O'Mahony SM, Neurogastroenterol Motil 2011 23 187 192 10.1111/j.1365-2982.2010.01664.x 21303428
20. Gut feelings: the emerging biology of gut-brain communication. Mayer EA, Nat Rev Neurosci 2011 12 453 466 21750565
21. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF, Proc Natl Acad Sci USA 2011 108 16050 16055 10.1073/pnas.1102999108 21876150
22. Brain-gut-microbe communication in health and disease. Grenham S, Clarke G, Cryan JF, Dinan TG, Front Physiol 2011 2 94 22162969
23. Host-bacterial mutualism in the human intestine. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI, Science 2005 307 1915 1920 10.1126/science.1104816 15790844 (Pubitemid 40404694)
24. Microbial ecology: human gut microbes associated with obesity. Ley RE, Turnbaugh PJ, Klein S, Gordon JI, Nature 2006 444 1022 1023 10.1038/4441022a 17183309 (Pubitemid 46018512)
25. Human gut microbiota in obesity and after gastric bypass. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, Krajmalnik-Brown R, Proc Natl Acad Sci USA 2009 106 2365 2370 10.1073/pnas.0812600106 19164560
26. Diversity of the human intestinal microbial flora. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA, Science 2005 308 1635 1638 10.1126/science.1110591 15831718 (Pubitemid 40807514)
27. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, Hirabara SM, Castoldi A, Vieira P, Camara NO, et al. PLoS Biol 2011 9 1001212 10.1371/journal.pbio.1001212 22162948
28. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT, Gut 1987 28 1221 1227 10.1136/gut.28.10.1221 3678950 (Pubitemid 17156038)
29. The contribution of the large intestine to energy supplies in man. McNeil NI, Am J Clin Nutr 1984 39 338 342 6320630 (Pubitemid 14186434)
30. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. Zaibi MS, Stocker CJ, O'Dowd J, Davies A, Bellahcene M, Cawthorne MA, Brown AJ, Smith DM, Arch JR, FEBS Lett 2010 584 2381 2386 10.1016/j.febslet.2010.04.027 20399779
31. Gut microbiota in health and disease. Sekirov I, Russell SL, Antunes LC, Finlay BB, Physiol Rev 2010 90 859 904 10.1152/physrev.00045.2009 20664075
32. Mood and gut feelings. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J, Brain Behav Immun 2010 24 9 16 10.1016/j.bbi.2009.05.058 19481599
33. Obesity alters gut microbial ecology. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI, Proc Natl Acad Sci USA 2005 102 11070 11075 10.1073/pnas.0504978102 16033867 (Pubitemid 41105994)
34. An obesity-associated gut microbiome with increased capacity for energy harvest. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI, Nature 2006 444 1027 1031 10.1038/nature05414 17183312 (Pubitemid 46018515)
35. Metabolic endotoxemia initiates obesity and insulin resistance. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Diabetes 2007 56 1761 1772 10.2337/db06-1491 17456850 (Pubitemid 47025442)
36. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJ, Velloso LA, Endocrinology 2005 146 4192 4199 10.1210/en.2004-1520 16002529 (Pubitemid 41324012)
37. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D, Cell 2008 135 61 73 10.1016/j.cell.2008.07.043 18854155
38. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, Tsukumo DM, Anhe G, Amaral ME, Takahashi HK, et al. J Neurosci 2009 29 359 370 19144836
39. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. Ropelle ER, Flores MB, Cintra DE, Rocha GZ, Pauli JR, Morari J, de Souza CT, Moraes JC, Prada PO, Guadagnini D, et al. PLoS Biol 2010 8 1000465 10.1371/journal.pbio. 1000465 20808781
40. Differences in diet between the 19th and 21st centuries: could they lead to insulin and leptin resistance and inflammation? Duarte Pimentel G, Rosa JC, Santos de Lira F, Endocrinol Nutr 2011 58 252 254 10.1016/j.endonu.2011.02.007 21530426
41. Gut microbiota, epithelial function and derangements in obesity. Raybould HE, J Physiol 2012 590 441 446 22183718
42. Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus. Duparc T, Naslain D, Colom A, Muccioli GG, Massaly N, Delzenne NM, Valet P, Cani PD, Knauf C, Antioxid Redox Signal 2011 14 415 423 10.1089/ars.2010.3330 20879900
43. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, Jobin C, Lund PK, PLoS One 2010 5 12191 10.1371/journal.pone.0012191 20808947
44. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE, Am J Physiol Gastrointest Liver Physiol 2010 299 440 G448 10.1152/ajpgi.00098.2010 20508158
45. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Monte SV, Caruana JA, Ghanim H, Sia CL, Korzeniewski K, Schentag JJ, Dandona P, Surgery 2012 151 587 593 10.1016/j.surg.2011.09.038 22088821
46. G-protein-coupled receptors as fat sensors. Vinolo MA, Hirabara SM, Curi R, Curr Opin Clin Nutr Metab Care 2012 15 112 116 10.1097/MCO.0b013e32834f4598 22234165
47. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT, Science 2010 328 228 231 10.1126/science.1179721 20203013
48. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. Nature 2012 482 179 185 22297845
49. Linking long-term dietary patterns with gut microbial enterotypes. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Science 2011 334 105 108 10.1126/science.1208344 21885731
50. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G, Martines D, Am J Physiol Gastrointest Liver Physiol 2007 292 518 G525 17023554
51. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Suzuki T, Hara H, Nutr Metab (Lond) 2010 7 19 10.1186/1743-7075-7-19
52. Occludin: a novel integral membrane protein localizing at tight junctions. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, J Cell Biol 1993 123 1777 1788 10.1083/jcb.123.6.1777 8276896 (Pubitemid 24012933)
53. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S, J Cell Biol 1998 141 1539 1550 10.1083/jcb.141.7.1539 9647647 (Pubitemid 28309169)
54. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, et al. J Cell Biol 1998 142 117 127 10.1083/jcb.142.1.117 9660867 (Pubitemid 28341144)
55. Tight junction proteins. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE, Prog Biophys Mol Biol 2003 81 1 44 10.1016/S0079-6107(02)00037-8 12475568 (Pubitemid 35436609)
56. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R, Diabetes 2008 57 1470 1481 10.2337/db07-1403 18305141
57. Relationships between body mass index and short-circuit current in human duodenal and colonic mucosal biopsies. Osbak PS, Bindslev N, Hansen MB, Acta Physiol (Oxf) 2011 201 47 53 10.1111/j.1748-1716.2010.02202.x
58. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Kremen AJ, Linner JH, Nelson CH, Ann Surg 1954 140 439 448 10.1097/00000658-195409000-00018 13198079
59. Bariatric surgery and long-term cardiovascular events. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, et al. JAMA 2012 307 56 65 10.1001/jama.2011.1914 22215166
60. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. Evans S, Pamuklar Z, Rosko J, Mahaney P, Jiang N, Park C, Torquati A, Surg Endosc 2012 26 1086 1094 10.1007/s00464-011-2004-7 22044971
61. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. Morinigo R, Moize V, Musri M, Lacy AM, Navarro S, Marin JL, Delgado S, Casamitjana R, Vidal J, J Clin Endocrinol Metab 2006 91 1735 1740 10.1210/jc.2005-0904 16478824
62. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. Falken Y, Hellstrom PM, Holst JJ, Naslund E, J Clin Endocrinol Metab 2011 96 2227 2235 10.1210/jc.2010-2876 21543426
63. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. Beckman LM, Beckman TR, Earthman CP, J Am Diet Assoc 2010 110 571 584 10.1016/j.jada.2009.12.023 20338283
64. Ulcerative colitis. Danese S, Fiocchi C, N Engl J Med 2011 365 1713 1725 10.1056/NEJMra1102942 22047562
65. Clinical features and management of duodenal fistula in patients with Crohn's disease. Uchino M, Ikeuchi H, Matsuoka H, Matsumoto T, Takesue Y, Tomita N, Hepatogastroenterology 2012 59 171 174 22251533
66. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ, Gut 2012
67. Regulation of short-chain fatty acid production. Macfarlane S, Macfarlane GT, Proc Nutr Soc 2003 62 67 72 10.1079/PNS2002207 12740060 (Pubitemid 36569810)
68. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L, BMC Microbiol 2011 11 7 10.1186/1471-2180-11-7 21219646
69. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM, Am J Gastroenterol 2011 106 329 336 10.1038/ajg.2010.438 21102570
70. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Cario E, Podolsky DK, Infect Immun 2000 68 7010 7017 10.1128/IAI.68.12.7010-7017.2000 11083826 (Pubitemid 32463415)
71. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW, Gastroenterology 2006 130 304 311 10.1053/j.gastro.2005.11.033 16472586 (Pubitemid 43202030)
72. Role of serum cytokine profile in ulcerative colitis assessment. Rodriguez-Perlvarez ML, Sanchez VG, Pastor CM, Gonzalez R, Flores EI, Muntane J, Camacho FG, Inflamm Bowel Dis 2012
73. Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, et al. JAMA 2011 306 2331 2339 10.1001/jama.2011.1692 22056398
74. Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. Wang K, Yuan CP, Wang W, Yang ZQ, Cui W, Mu LZ, Yue ZP, Yin XL, Hu ZM, Liu JX, World J Gastroenterol 2010 16 2252 2259 10.3748/wjg.v16.i18.2252 20458762
75. Neural regulators of innate immune responses and inflammation. Pavlov VA, Tracey KJ, Cell Mol Life Sci 2004 61 2322 2331 15378203 (Pubitemid 39382024)
76. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A, Am J Gastroenterol 2005 100 373 382 10.1111/j.1572-0241.2005.40312.x 15667495 (Pubitemid 40314522)
77. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM, World J Gastroenterol 2009 15 2887 2892 10.3748/wjg.15.2887 19533811
78. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR, Proc Natl Acad Sci USA 2007 104 13780 13785 10.1073/pnas.0706625104 17699621 (Pubitemid 350003397)
79. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM, Gastroenterology 2011 141 1792 1801 10.1053/j.gastro.2011.07.043 21820992
80. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM, Diabetologia 2007 50 2374 2383 10.1007/s00125-007-0791-0 17823788 (Pubitemid 47512397)
81. Effect of fiber supplementation on the microbiota in critically ill patients. O'Keefe SJ, Ou J, Delany JP, Curry S, Zoetendal E, Gaskins HR, Gunn S, World J Gastrointest Pathophysiol 2011 2 138 145 10.4291/wjgp.v2.i6.138 22180847
82. Gut microbiota and probiotics in maternal and infant health. Sanz Y, Am J Clin Nutr 2011 94 2000S 2005S 10.3945/ajcn.110.001172 21543533
83. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, et al. Sci Transl Med 2011 3 106ra106 10.1126/scitranslmed.3002701 22030749
84. New insights into the impact of the intestinal microbiota on health and disease: a symposium report. Thomas LV, Ockhuizen T, Br J Nutr 2012 107 Suppl 1 1 S13 22260731
85. Do probiotics improve symptoms in patients with irritable bowel syndrome? Whorwell PJ, Therap Adv Gastroenterol 2009 2 37 44 10.1177/1756283X09335637 21180553
86. Gut microbiota and inflammation. Hakansson A, Molin G, Nutrients 2011 3 637 682 10.3390/nu3060637 22254115
87. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM, Gut 2006 55 1553 1560 10.1136/gut.2005.080739 16638791 (Pubitemid 44629200)
88. Adhesive capability of Lactobacillus plantarum 299v is important for preventing bacterial translocation in endotoxemic rats. Mangell P, Lennernas P, Wang M, Olsson C, Ahrne S, Molin G, Thorlacius H, Jeppsson B, APMIS 2006 114 611 618 10.1111/j.1600-0463.2006.apm-369.x 16948813 (Pubitemid 44337339)
89. Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Reimer RA, McBurney MI, Endocrinology 1996 137 3948 3956 10.1210/en.137.9.3948 8756571 (Pubitemid 26284671)
90. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Tarini J, Wolever TM, Appl Physiol Nutr Metab 2010 35 9 16 10.1139/H09-119 20130660
91. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, Francois P, de Vos WM, et al. Diabetes 2011 60 2775 2786 10.2337/db11-0227 21933985
92. The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes. Roelofsen H, Priebe MG, Vonk RJ, Benef Microbes 2010 1 433 437 10.3920/BM2010.0028 21831781
93. A water-soluble fraction from a by-product of wheat increases the formation of propionic acid in rats compared with diets based on other by-product fractions and oligofructose. Haska L, Andersson R, Nyman M, Food Nutr Res 2011
94. Macrophage-mediated inflammation in metabolic disease. Chawla A, Nguyen KD, Goh YP, Nat Rev Immunol 2011 11 738 749 10.1038/nri3071 21984069
95. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM, Cell 2010 142 687 698 10.1016/j.cell.2010.07.041 20813258
96. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Cunningham-Rundles S, Ahrne S, Johann-Liang R, Abuav R, Dunn-Navarra AM, Grassey C, Bengmark S, Cervia JS, Nutrients 2011 3 1042 1070 10.3390/nu3121042 22292110
97. Contribution of gut microbiota to colonic and extracolonic cancer development. Compare D, Nardone G, Dig Dis 2011 29 554 561 10.1159/000332967 22179211
98. Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance. Pimentel GD, Portero-McLellan KC, Oliveira EP, Spada AP, Oshiiwa M, Zemdegs JC, Barbalho SM, Nutr Res 2010 30 186 190 10.1016/j.nutres.2010.03.003 20417879
99. Short-term nutritional counseling reduces body mass index, waist circumference, triceps skinfold and triglycerides in women with metabolic syndrome. Pimentel GD, Arimura ST, de Moura BM, Silva ME, de Sousa MV, Diabetol Metab Syndr 2010 2 13 10.1186/1758-5996-2-13 20181143
100. Human nutrition, the gut microbiome and the immune system. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI, Nature 2011 474 327 336 10.1038/nature10213 21677749